• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2007-2008 年,乌干达邦迪布焦地区由一种新鉴定病毒株引起的埃博拉出血热的临床表现和病例管理。

Clinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008.

机构信息

Medical Departments of Médecins Sans Frontières, Barcelona, Spain.

出版信息

PLoS One. 2012;7(12):e52986. doi: 10.1371/journal.pone.0052986. Epub 2012 Dec 28.

DOI:10.1371/journal.pone.0052986
PMID:23285243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3532309/
Abstract

A confirmed Ebola haemorrhagic fever (EHF) outbreak in Bundibugyo, Uganda, November 2007-February 2008, was caused by a putative new species (Bundibugyo ebolavirus). It included 93 putative cases, 56 laboratory-confirmed cases, and 37 deaths (CFR = 25%). Study objectives are to describe clinical manifestations and case management for 26 hospitalised laboratory-confirmed EHF patients. Clinical findings are congruous with previously reported EHF infections. The most frequently experienced symptoms were non-bloody diarrhoea (81%), severe headache (81%), and asthenia (77%). Seven patients reported or were observed with haemorrhagic symptoms, six of whom died. Ebola care remains difficult due to the resource-poor setting of outbreaks and the infection-control procedures required. However, quality data collection is essential to evaluate case definitions and therapeutic interventions, and needs improvement in future epidemics. Organizations usually involved in EHF case management have a particular responsibility in this respect.

摘要

2007 年 11 月至 2008 年 2 月,乌干达邦迪布焦暴发了一起埃博拉出血热(EHF)确诊疫情,由一种假定的新物种(邦迪布焦埃博拉病毒)引起。共报告了 93 例疑似病例,56 例实验室确诊病例,37 例死亡(病死率为 25%)。本研究的目的是描述 26 例住院治疗的实验室确诊埃博拉出血热患者的临床表现和病例管理。临床发现与先前报告的埃博拉出血热感染一致。最常经历的症状是非血性腹泻(81%)、严重头痛(81%)和乏力(77%)。7 名患者报告或观察到有出血症状,其中 6 人死亡。由于暴发时资源匮乏和需要感染控制程序,埃博拉护理仍然很困难。然而,为了评估病例定义和治疗干预措施,高质量的数据收集是必不可少的,在未来的疫情中需要加以改进。在这方面,通常参与埃博拉出血热病例管理的组织负有特殊责任。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd1d/3532309/821228d63545/pone.0052986.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd1d/3532309/bb995530bdb8/pone.0052986.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd1d/3532309/1dcd378b9919/pone.0052986.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd1d/3532309/a0b794d7f0f4/pone.0052986.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd1d/3532309/821228d63545/pone.0052986.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd1d/3532309/bb995530bdb8/pone.0052986.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd1d/3532309/1dcd378b9919/pone.0052986.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd1d/3532309/a0b794d7f0f4/pone.0052986.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd1d/3532309/821228d63545/pone.0052986.g004.jpg

相似文献

1
Clinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008.2007-2008 年,乌干达邦迪布焦地区由一种新鉴定病毒株引起的埃博拉出血热的临床表现和病例管理。
PLoS One. 2012;7(12):e52986. doi: 10.1371/journal.pone.0052986. Epub 2012 Dec 28.
2
Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda.乌干达邦迪布焦埃博拉病毒感染的死亡比例和临床特征。
Emerg Infect Dis. 2010 Dec;16(12):1969-72. doi: 10.3201/eid1612.100627.
3
Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda.新发现的与乌干达出血热疫情相关的埃博拉病毒。
PLoS Pathog. 2008 Nov;4(11):e1000212. doi: 10.1371/journal.ppat.1000212. Epub 2008 Nov 21.
4
Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007-2008.2007-2008 年乌干达新型病毒株引起的埃博拉出血热。
Emerg Infect Dis. 2010 Jul;16(7):1087-92. doi: 10.3201/eid1607.091525.
5
Filovirus outbreak detection and surveillance: lessons from Bundibugyo.丝状病毒爆发的检测与监测:来自邦迪布焦的经验教训。
J Infect Dis. 2011 Nov;204 Suppl 3:S761-7. doi: 10.1093/infdis/jir294.
6
Ebola haemorrhagic fever among hospitalised children and adolescents in northern Uganda: epidemiologic and clinical observations.乌干达北部住院儿童和青少年中的埃博拉出血热:流行病学和临床观察
Afr Health Sci. 2001 Dec;1(2):60-5.
7
Ebola virus outbreaks in Africa: past and present.非洲的埃博拉病毒疫情:过去与现在
Onderstepoort J Vet Res. 2012 Jun 20;79(2):451. doi: 10.4102/ojvr.v79i2.451.
8
Ebola haemorrhagic fever.埃博拉出血热
Nurs Stand. 2001;15(32):40-2. doi: 10.7748/ns2001.04.15.32.40.c3019.
9
Containing a haemorrhagic fever epidemic: the Ebola experience in Uganda (October 2000-January 2001).遏制出血热疫情:乌干达的埃博拉疫情经历(2000年10月 - 2001年1月)
Int J Infect Dis. 2004 Jan;8(1):27-37. doi: 10.1016/j.ijid.2003.04.001.
10
Reduced virus replication, proinflammatory cytokine production, and delayed macrophage cell death in human PBMCs infected with the newly discovered Bundibugyo ebolavirus relative to Zaire ebolavirus.与扎伊尔埃博拉病毒相比,新发现的本迪布焦埃博拉病毒感染的人 PBMC 中病毒复制减少、促炎细胞因子产生减少和巨噬细胞细胞死亡延迟。
Virology. 2010 Jun 20;402(1):203-8. doi: 10.1016/j.virol.2010.03.024. Epub 2010 Apr 14.

引用本文的文献

1
Non-Ebola Filoviruses: Potential Threats to Global Health Security.非埃博拉丝状病毒:对全球卫生安全的潜在威胁。
Viruses. 2024 Jul 23;16(8):1179. doi: 10.3390/v16081179.
2
An update on nonhuman primate usage for drug and vaccine evaluation against filoviruses.关于用于评估抗丝状病毒药物和疫苗的非人类灵长类动物使用的最新进展。
Expert Opin Drug Discov. 2024 Oct;19(10):1185-1211. doi: 10.1080/17460441.2024.2386100. Epub 2024 Aug 18.
3
A Recombinant Vesicular Stomatitis Virus-Based Vaccine Provides Postexposure Protection Against Bundibugyo Ebolavirus Infection.

本文引用的文献

1
Filovirus hemorrhagic fever outbreak case management: a review of current and future treatment options.丝状病毒出血热疫情病例管理:当前和未来治疗选择综述。
J Infect Dis. 2011 Nov;204 Suppl 3:S791-5. doi: 10.1093/infdis/jir297.
2
The use of a mobile laboratory unit in support of patient management and epidemiological surveillance during the 2005 Marburg Outbreak in Angola.在 2005 年安哥拉马尔堡疫情期间,使用移动实验室单位支持患者管理和流行病学监测。
PLoS Negl Trop Dis. 2011 May;5(5):e1183. doi: 10.1371/journal.pntd.0001183. Epub 2011 May 24.
3
Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda.
一种基于重组水疱性口炎病毒的疫苗可提供暴露后针对邦迪布焦埃博拉病毒感染的保护。
J Infect Dis. 2023 Nov 15;228(Suppl 7):S712-S720. doi: 10.1093/infdis/jiad207.
4
Containment of a fatal and highly infectious disease outbreak.控制致命且高度传染性疾病的爆发。
Pan Afr Med J. 2021 Dec 16;40(Suppl 2):2. doi: 10.11604/pamj.supp.2021.40.2.30897. eCollection 2021.
5
Drivers of African Filovirus (Ebola and Marburg) Outbreaks.非洲丝状病毒(埃博拉和马尔堡)疫情的驱动因素。
Vector Borne Zoonotic Dis. 2022 Sep;22(9):478-490. doi: 10.1089/vbz.2022.0020.
6
Functional implications of the CpG island methylation in the pathogenesis of celiac disease.CpG 岛甲基化在乳糜泻发病机制中的功能意义。
Mol Biol Rep. 2022 Oct;49(10):10051-10064. doi: 10.1007/s11033-022-07585-w. Epub 2022 May 28.
7
Molecular analysis of the 2012 Bundibugyo virus disease outbreak.分子分析 2012 年邦迪布尤病毒病疫情
Cell Rep Med. 2021 Jul 27;2(8):100351. doi: 10.1016/j.xcrm.2021.100351. eCollection 2021 Aug 17.
8
Comparison of Zaire and Bundibugyo Ebolavirus Polymerase Complexes and Susceptibility to Antivirals through a Newly Developed Bundibugyo Minigenome System.扎伊尔埃博拉病毒和本迪布焦埃博拉病毒聚合酶复合物的比较及通过新建立的本迪布焦小基因文库系统对其抗病毒药物敏感性的研究
J Virol. 2021 Sep 27;95(20):e0064321. doi: 10.1128/JVI.00643-21. Epub 2021 Aug 11.
9
Meta-analysis of predictive symptoms for Ebola virus disease.埃博拉病毒病预测症状的荟萃分析。
PLoS Negl Trop Dis. 2020 Oct 23;14(10):e0008799. doi: 10.1371/journal.pntd.0008799. eCollection 2020 Oct.
10
Sociodemographic and clinical determinants of in-facility case fatality rate for 938 adult Ebola patients treated at Sierra Leone Ebola treatment center.在塞拉利昂埃博拉治疗中心接受治疗的938名成年埃博拉患者的院内病死率的社会人口学和临床决定因素。
BMC Infect Dis. 2020 Apr 21;20(1):293. doi: 10.1186/s12879-020-04994-9.
乌干达邦迪布焦埃博拉病毒感染的死亡比例和临床特征。
Emerg Infect Dis. 2010 Dec;16(12):1969-72. doi: 10.3201/eid1612.100627.
4
Factors associated with Marburg hemorrhagic fever: analysis of patient data from Uige, Angola.与马尔堡出血热相关的因素:安哥拉威热省患者数据的分析。
J Infect Dis. 2010 Jun 15;201(12):1909-18. doi: 10.1086/652748.
5
Imported case of Marburg hemorrhagic fever - Colorado, 2008.2008年科罗拉多州马尔堡出血热输入病例
MMWR Morb Mortal Wkly Rep. 2009 Dec 18;58(49):1377-81.
6
Experimental vaccine may have saved Hamburg scientist from Ebola fever.实验性疫苗或许使这位汉堡科学家免于感染埃博拉热。
BMJ. 2009 Mar 23;338:b1223. doi: 10.1136/bmj.b1223.
7
Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda.新发现的与乌干达出血热疫情相关的埃博拉病毒。
PLoS Pathog. 2008 Nov;4(11):e1000212. doi: 10.1371/journal.ppat.1000212. Epub 2008 Nov 21.
8
Filoviruses. A compendium of 40 years of epidemiological, clinical, and laboratory studies.丝状病毒。40年流行病学、临床和实验室研究综述。
Arch Virol Suppl. 2008;20:13-360.
9
Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions.马尔堡出血热和埃博拉出血热的治疗:在疫情爆发情况下测试新药和疫苗的策略。
Antiviral Res. 2008 Apr;78(1):150-61. doi: 10.1016/j.antiviral.2008.01.152. Epub 2008 Feb 26.
10
Filovirus research: knowledge expands to meet a growing threat.丝状病毒研究:知识不断拓展以应对日益增长的威胁。
J Infect Dis. 2007 Nov 15;196 Suppl 2:S438-43. doi: 10.1086/520552.